ribavirin has been researched along with AIDS-Related Opportunistic Infections in 48 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (18.75) | 18.2507 |
| 2000's | 29 (60.42) | 29.6817 |
| 2010's | 10 (20.83) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Biasi, C; Dukan, P; Javelle, E; Lightburne, E; Morand, JJ | 1 |
| Hirashima, N; Imamura, J; Iwase, H; Shimada, M; Sugiura, W; Watanabe, T; Yokomaku, Y | 1 |
| Neumaier, J | 1 |
| Gasiorowski, J; Inglot, M; Szymczak, A | 1 |
| Brinkmann, K; Sabranski, M; Stoehr, A | 1 |
| Denholm, JT; Sasadeusz, JJ; Street, A; Wright, EJ | 1 |
| Pol, S | 3 |
| Bani-Sadr, F | 1 |
| Piroth, L | 1 |
| Molina, JM; Palmer, P; Rachline, A; Simon, F | 1 |
| Boesecke, C; Rockstroh, JK; Vogel, M; Wasmuth, JC | 1 |
| Bernasconi, E; Borovicka, J; Cavassini, M; Cerny, A; Chave, JP; Chuard, C; Dufour, F; Dutoit, V; Genné, D; Gonvers, JJ; Heim, MH; Malinverni, R; Monnat, M; Müllhaupt, B; Negro, F; Oneta, C; Troilliet, N | 1 |
| Barreiro, P; Benito, JM; Camacho, A; Caruz, A; Labarga, P; Mira, JA; Neukam, K; Pineda, JA; Pinilla, J; Rallón, N; Rivero, A; Rodriguez-Novoa, S; Soriano, V; Vispo, E | 1 |
| Camacho, A; Caruz, A; Di Lello, FA; Gómez-Mateos, J; Macías, J; Mesa, P; Neukam, K; Pineda, JA; Rivero, A; Rivero-juárez, A | 1 |
| Chung, TL; Haagmans, BL; Herrmann, E; Kottilil, S; Lempicki, RA; Murphy, AA; Osinusi, AO; Polis, MA; Sachau, W; Wood, BJ; Wu, L; Yang, J | 1 |
| Arends, JE; van den Berk, GE | 1 |
| Hernández, ML | 1 |
| Mauss, S | 1 |
| Santos Gil, I; Sanz Sanz, J | 1 |
| Arizcorreta, A; Brun, F; Fernández-Gutiérrez, C; García Juárez, R; Girón-González, JA; Guerrero, F; Pérez-Guzmán, E | 1 |
| Baumgarten, A; Bieniek, B; Bogner, JR; Hoffmann, C; Jessen, H; Kroidl, A; Rockstroh, JK; Schewe, CK; Spengler, U; Vogel, M | 1 |
| Jabłonowska, E | 1 |
| Zeuzem, S | 1 |
| Eyster, ME; Horn, PS; Rouster, SD; Sherman, KE; Shire, NJ; Stanford, S | 1 |
| Lindhardt, BØ; Peters, L | 2 |
| Campos, NG; Freedberg, KA; Goldie, SJ; Nunes, DP; Salomon, JA; Samet, JH; Servoss, JC | 1 |
| Aoki, FH; Gonçalves, FL; Pavan, MH; Velho, PE; Vigani, AG | 1 |
| Morris, DJ | 1 |
| Shaunak, S; Sriskandan, S | 1 |
| Girard, PM; Guessant, S; Maslo, C; Rozenbaum, W; Urban, T | 1 |
| Begemann, F; Jablonowski, H | 1 |
| Faris, M; O'Riordan, T | 1 |
| Goebel, FD; Jablonowski, H | 1 |
| Mast, EE; Seeff, LB; Sulkowski, MS; Thomas, DL | 1 |
| Hayden, FG | 1 |
| Ghosh, S; Whimbey, E | 1 |
| De Bona, A; Finazzi, R; Foppa, CU; Lazzarin, A; Morsica, G; Sitia, G | 1 |
| Rivero, A; Torre-Cisneros, J | 1 |
| Laurence, J | 1 |
| Fernández, I; Lumbreras, C; Rubio, R | 1 |
14 review(s) available for ribavirin and AIDS-Related Opportunistic Infections
| Article | Year |
|---|---|
[Current opportunities for treatment of chronic hepatitis C in patients with HIV co-infection].
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Comorbidity; Evidence-Based Medicine; Hepatitis C, Chronic; Humans; Interferons; Poland; Primary Health Care; Randomized Controlled Trials as Topic; Ribavirin; Risk Assessment | 2008 |
[HIV and hepatitis C co-infection].
Topics: AIDS-Related Opportunistic Infections; Algorithms; Antiretroviral Therapy, Highly Active; Antiviral Agents; Cross-Sectional Studies; Evidence-Based Medicine; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Practice Guidelines as Topic; Recombinant Proteins; Ribavirin | 2010 |
[Coinfection with HIV and HCV--epidemiologic, diagnostic, clinical and therapeutic implications].
Topics: AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Antiviral Agents; Disease Progression; Drug Therapy, Combination; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Ribavirin; Risk Factors | 2004 |
[Treatment of hepatitis C virus infection].
Topics: Acute Disease; AIDS-Related Opportunistic Infections; Antiviral Agents; Clinical Trials as Topic; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Longitudinal Studies; Meta-Analysis as Topic; Polyethylene Glycols; Recombinant Proteins; Recurrence; Ribavirin; Risk Factors; RNA, Viral; Time Factors; Viral Load | 2005 |
[Acute hepatitis C virus infection--clinical manifestations, diagnosis and treatment].
Topics: Acute Disease; AIDS-Related Opportunistic Infections; Antiviral Agents; Drug Therapy, Combination; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome | 2006 |
[Treatment of hepatitis C virus infection in patients with concurrent human immunodeficiency virus infection].
Topics: AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Antiviral Agents; Drug Therapy, Combination; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Practice Guidelines as Topic; Recombinant Proteins; Ribavirin; Treatment Outcome | 2006 |
Adverse effects and drug interactions of clinical importance with antiviral drugs.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Amantadine; Antiviral Agents; Didanosine; Drug Interactions; Foscarnet; Ganciclovir; Humans; Interferon-alpha; Ribavirin; Rimantadine; Vidarabine; Zalcitabine; Zidovudine | 1994 |
[International consensus conference on hepatitis C. Conclusions. Organized under the auspices of the European Association for the Study of the Liver (EASL)].
Topics: Adult; Age Factors; Aged; AIDS-Related Opportunistic Infections; Alcoholism; Antiviral Agents; Child; Child, Preschool; Clinical Trials as Topic; Diagnosis, Differential; Drug Therapy, Combination; Hepacivirus; Hepatitis C; Humans; Interferons; Liver Transplantation; Recurrence; Ribavirin; Risk Factors; RNA, Viral; Substance-Related Disorders; Viral Hepatitis Vaccines | 1999 |
Inhaled antimicrobial therapy.
Topics: Administration, Inhalation; Aerosols; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antiviral Agents; Bronchitis; Colony Count, Microbial; Cystic Fibrosis; Humans; Lung Diseases; Pentamidine; Pneumonia, Pneumocystis; Respiration, Artificial; Ribavirin; Sputum; Tobramycin; Tracheitis | 1999 |
Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Hepatitis C; Humans; Interferon-alpha; Recurrence; Ribavirin | 2000 |
Prevention and treatment of influenza in immunocompromised patients.
Topics: Aerosols; AIDS-Related Opportunistic Infections; Amantadine; Antiviral Agents; Bone Marrow Transplantation; Drug Resistance, Microbial; Humans; Immunocompromised Host; Influenza Vaccines; Influenza, Human; Infusions, Intravenous; Organ Transplantation; Orthomyxoviridae; Primary Prevention; Ribavirin; Rimantadine | 1997 |
Respiratory syncytial virus infections in immunocompromised adults.
Topics: Administration, Inhalation; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Diagnosis, Differential; Humans; Immunization, Passive; Immunocompromised Host; Leukemia; Pneumonia; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin; Steroids; Virion | 2000 |
Bullet points: new topics in HIV/AIDS.
Topics: AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Antiviral Agents; Hepatitis C, Chronic; HIV Infections; Humans; Lipids; Protease Inhibitors; Ribavirin | 2002 |
Hepatitis C in HIV-infected patients--therapeutic approach.
Topics: AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Antiviral Agents; Drug Therapy, Combination; Hepatitis C; Humans; Interferon-alpha; Liver Transplantation; Ribavirin | 2002 |
7 trial(s) available for ribavirin and AIDS-Related Opportunistic Infections
| Article | Year |
|---|---|
[In HIV-HCV co-infection check for drug interactions].
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Carbamates; Compassionate Use Trials; Drug Interactions; Drug Therapy, Combination; Hepatitis C, Chronic; HIV Infections; Imidazoles; Pyrrolidines; Ribavirin; Sofosbuvir; Valine | 2016 |
Treatment of hepatitis C in HCV mono-infected and in HIV-HCV co-infected patients: an open-labelled comparison study.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Antiviral Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Long-Term Care; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome; Viral Load | 2010 |
Twice-weekly pegylated interferon-α-2a and ribavirin results in superior viral kinetics in HIV/hepatitis C virus co-infected patients compared to standard therapy.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Black or African American; Drug Administration Schedule; Female; Genotype; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Pilot Projects; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome; Virus Replication; Young Adult | 2011 |
[Treatment with interferon and ribavirin of chronic hepatitis C in HIV-infected patients].
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; HIV-1; Humans; Interferon alpha-2; Interferon-alpha; Recombinant Proteins; Ribavirin; Treatment Outcome | 2004 |
Modifications of haematological series in patients co-infected with human immunodeficiency virus and hepatitis C virus during treatment with interferon and ribavirin: differences between pegylated and standard interferon.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Blood Cell Count; Drug Therapy, Combination; Female; Hematologic Diseases; Hemorrhage; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin | 2004 |
HCV kinetics, quasispecies, and clearance in treated HCV-infected and HCV/HIV-1-coinfected patients with hemophilia.
Topics: Adult; AIDS-Related Opportunistic Infections; Alanine Transaminase; Antiviral Agents; CD4-Positive T-Lymphocytes; Female; Follow-Up Studies; Hemophilia A; Hepacivirus; Hepatitis C; HIV Infections; HIV-1; Humans; Interferon-alpha; Male; Middle Aged; Remission Induction; Ribavirin; RNA, Viral; Viral Load | 2006 |
Therapy of special HIV-associated diseases: HCV-HIV-co-infection and AIDS-related Kaposi's sarcoma - official satellite to the 7th European Conference on Clinical Aspects and Treatment of HIV-infection, October 23, 1999 in Lisbon, Portugal.
Topics: AIDS-Related Opportunistic Infections; Antibiotics, Antineoplastic; Antiviral Agents; Cost-Benefit Analysis; Daunorubicin; Doxorubicin; Hepatitis C, Chronic; Herpesvirus 8, Human; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Recombinant Proteins; Ribavirin; Sarcoma, Kaposi | 1999 |
27 other study(ies) available for ribavirin and AIDS-Related Opportunistic Infections
| Article | Year |
|---|---|
Human immunodeficiency virus (HIV)-associated epidermodysplasia verruciformis eradicated after interferon-α and ribavirin treatment.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Coinfection; Epidermodysplasia Verruciformis; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Papillomaviridae; Ribavirin | 2014 |
An Hepatitis C Virus (HCV)/HIV Co-Infected Patient who Developed Severe Hepatitis during Chronic HCV Infection: Sustained Viral Response with Simeprevir Plus Peginterferon-Alpha and Ribavirin.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Coinfection; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Severity of Illness Index; Simeprevir; Treatment Outcome | 2015 |
[HIV and hepatitis C coinfection].
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Factors; Viral Load | 2008 |
HCV treatment with pegylated interferon and ribavirin in patients with haemophilia and HIV/HCV co-infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Australia; Genotype; Hemophilia A; Hepacivirus; HIV-1; Humans; Interferons; Male; Middle Aged; Retrospective Studies; Ribavirin; Treatment Outcome | 2009 |
[ANRS HC 02 RIBAVIC: histo-pathological impact].
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Biopsy; Drug Therapy, Combination; France; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Liver; Liver Cirrhosis; Multivariate Analysis; Polyethylene Glycols; Randomized Controlled Trials as Topic; Recombinant Proteins; Ribavirin; Severity of Illness Index; Treatment Outcome | 2009 |
[ANRS HC 02 RIBAVIC: from multicenter trial to daily practice].
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Comorbidity; Drug Therapy, Combination; France; Government Agencies; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Multicenter Studies as Topic; Polyethylene Glycols; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Recombinant Proteins; Ribavirin; Treatment Outcome | 2009 |
[ANRS HC 02 RIBAVIC: from multicenter trial to daily practice. Conclusions].
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Drug Therapy, Combination; France; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Multicenter Studies as Topic; Polyethylene Glycols; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Recombinant Proteins; Ribavirin; Treatment Outcome | 2009 |
[Treatment of chronic hepatitis C in HIV-infected patients].
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Clinical Trials as Topic; Congresses as Topic; Drug Therapy, Combination; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Practice Guidelines as Topic; Recombinant Proteins; Ribavirin; Risk Factors; Treatment Outcome | 2009 |
[HIV-HCV co-infection: where are we now?].
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Clinical Trials as Topic; Comorbidity; France; Hepacivirus; Hepatitis C; HIV; HIV Infections; Humans; Incidence; Interferon alpha-2; Interferon-alpha; Interferons; Prevalence; Prognosis; Recombinant Proteins; Ribavirin; Risk Factors; Treatment Outcome | 2009 |
Case report: Cure of chronic infection with hepatitis C virus after 6 weeks of peg-interferon and ribavirin in a patient co-infected with HIV.
Topics: Administration, Cutaneous; AIDS-Related Opportunistic Infections; Antiviral Agents; Drug Therapy, Combination; Hepatitis C, Chronic; HIV-1; Humans; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome; Viral Load | 2010 |
Impact of IL28B polymorphisms on response to peginterferon and ribavirin in HIV–hepatitis C virus-coinfected patients with prior nonresponse or relapse.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Polymorphism, Genetic; Recombinant Proteins; Recurrence; Ribavirin | 2011 |
Low-density lipoprotein receptor genotyping enhances the predictive value of IL28B genotype in HIV/hepatitis C virus-coinfected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Female; Genotype; Hepatitis C; HIV Infections; HIV-1; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Interleukins; Male; Polyethylene Glycols; Predictive Value of Tests; Receptors, LDL; Recombinant Proteins; Ribavirin; RNA, Viral; Viral Load | 2011 |
Sustained viral response after only 6 weeks of peginterferon and ribavirin treatment for acute hepatitis C in a HIV-1-infected patient.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Drug Therapy, Combination; Hepatitis C; HIV Infections; HIV-1; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome | 2011 |
[Hepatitis? What is it?].
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Biomarkers; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2002 |
[Increasing chances. Effective HCV therapy lowers mortality of HIV infection].
Topics: AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Antiviral Agents; Cause of Death; Clinical Trials as Topic; Drug Therapy, Combination; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Survival Rate | 2003 |
[Progress in the treatment of hepatitis B and C co-infection in HIV patients].
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Comorbidity; Drug Therapy, Combination; Hepatitis B, Chronic; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Survival Rate | 2004 |
[APRICOT Study evaluated. Surprisingly high virologic response in HIV-HCV coinfection].
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Comorbidity; Drug Therapy, Combination; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Multicenter Studies as Topic; Polyethylene Glycols; Randomized Controlled Trials as Topic; Recombinant Proteins; Ribavirin; Viral Load | 2004 |
[Eliminating the gray zone. What can be done in normal ALT values?].
Topics: AIDS-Related Opportunistic Infections; Alanine Transaminase; Antiretroviral Therapy, Highly Active; Antiviral Agents; Drug Administration Schedule; Drug Therapy, Combination; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Liver Function Tests; Multicenter Studies as Topic; Polyethylene Glycols; Randomized Controlled Trials as Topic; Recombinant Proteins; Ribavirin; Treatment Outcome | 2004 |
Treatment of acute hepatitis C infection in HIV-infected patients: a retrospective analysis of eleven cases.
Topics: Acute Disease; AIDS-Related Opportunistic Infections; Antiviral Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Germany; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Assessment; Sampling Studies; Severity of Illness Index; Treatment Outcome; Viral Load | 2005 |
Cost-effectiveness of treatment for hepatitis C in an urban cohort co-infected with HIV.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Antiviral Agents; Cohort Studies; Cost of Illness; Cost-Benefit Analysis; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Markov Chains; Middle Aged; Recombinant Proteins; Ribavirin; Survival Analysis; Treatment Outcome; United States; Urban Health | 2007 |
Treatment of human papillomavirus with peg-interferon alfa-2b and ribavirin.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Drug Therapy, Combination; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Papillomavirus Infections; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome | 2007 |
Respiratory syncytial virus infection in an adult with AIDS.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Female; Humans; Middle Aged; Pneumonia, Viral; Respiratory Syncytial Virus Infections; Ribavirin | 1993 |
Ribavirin therapy for adenovirus pneumonia in an AIDS patient.
Topics: Adenovirus Infections, Human; Adenoviruses, Human; Adult; AIDS-Related Opportunistic Infections; Antibodies, Viral; Antiviral Agents; Biopsy; CD4 Lymphocyte Count; Fatal Outcome; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Pneumonia, Viral; Recurrence; Ribavirin; Tomography, X-Ray Computed | 1997 |
Enhancing the response to interferon-alpha.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Models, Biological; Recombinant Proteins; Ribavirin; Sarcoma, Kaposi | 1999 |
Ribavirin therapy for chronic hepatitis C does not modify HIV viral load in HIV-1 positive patients under antiretroviral treatment.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Antiviral Agents; Female; Hepatitis C, Chronic; HIV Seropositivity; HIV-1; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Recombinant Proteins; Ribavirin; RNA, Viral; Viral Load | 2000 |
Opportunistic infections update.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Drug Interactions; Drug Resistance, Microbial; Drug Therapy, Combination; Hepatitis B; Hepatitis C; HIV Infections; Humans; Interferon-alpha; Lamivudine; Liver; Ribavirin | 1998 |
[Management of chronic hepatitis C infection in patients infected with the human immunodeficiency virus: from what we know to what we ignore].
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon-alpha; Prognosis; Ribavirin | 2001 |